To further characterize spontaneous diabetes mellitus in cynomolgus macaques (Macaca fascicularis) as a model for human non-insulin-dependent diabetes mellitus (NIDDM), we evaluated the morphologic characteristics of the endocrine pancreas of 4 diabetic and 12 age-matched nondiabetic cynomolgus macaques. In addition, the cDNA-predicted amino acid sequence for islet amyloid polypeptide (IAPP) of this species was determined. Islet amyloid deposits exhibiting typical congophilia and green birefringence were found in 4/4 diabetic animals and in 8/ 12 nondiabetics. Islet amyloid deposits were significantly more extensive in the diabetic macaques ( P = O.OOl), in which they occupied a mean of 60% of the islet area. In contrast, in the nondiabetic group the maximum islet area occupied by amyloid was 24% (group mean = 6.8%), with four animals having no detectable islet amyloid. Amyloid deposits consistently showed immunoreactivity for IAPP but not for insulin. Comparisons between group means for diabetic versus nondiabetic macaques showed significantly greater islet area ( P = 0.01, 85,390 versus 36,540 wm2) and significantly greater islet area fraction ( P = 0.02,0.065 versus 0.032) for the diabetic group. The cDNA-predicted amino acid sequence for cynomolgus IAPP was identical to that previously reported for pig-tail macaques (M. nemestrina) and had 92%, 86%, and 84% amino acid sequence identity with human, domestic cat, and murine IAPPs, respectively. These findings support the use of cynomolgus macaques as an animal model of human NIDDM.
The clinical presentation of spontaneous diabetes mellitus in cynomolgus macaques (Macaca fascicularis) closely resembles that of human non-insulin-dependent diabetes mellitus (NIDDM). 29 The similarities include onset of diabetes in the middle to late years of life, obesity, hyperinsulinemia and/or blunted insulin response to intravenous glucose, and a long nonketotic phase during which insulin therapy is not needed. These provocative clinical similarities suggest that spontaneous diabetes mellitus in cynomolgus macaques can serve as an excellent animal model of human NIDDM. However, lesions in the pancreatic islets in this animal model have not been extensively documented.
In a preliminary study, we noted extensive amyloid deposits in the pancreatic islets of two diabetic cynomolgus macaques. 29 However, the prevalence, derivation, and extent of these deposits in aged nondiabetic and diabetic macaques is not known. By comparison, most (if not all) human patients with NIDDM develop amyloid deposits in their pancreatic islets (islet amyloid)1J0,21332 and concurrently lose a substantial portion of their beta cell mass.27~28~30 Similar pancreatic islet lesions occur in association with age-associated diabetes mellitus in domestic c a t~I~, *~ and in diabetes mellitus in other macaque species.'J1J2 Islet amyloid deposits in human patients with NIDDM and feline age-associated diabetes mellitus are derived from islet amyloid polypeptide (IAPP).6.33,34 IAPP, along with insulin, is normally produced and secreted by the pancreatic beta cells.4J4 The mechanisms by which IAPP, a normal beta cell product, undergoes assembly into amyloid deposits are not fully understood. However, one region of the mature IAPP molecule (i.e., secreted form), corresponding to residues 20-29, is most responsible for the propensity to assemble into amyloid fibrils. 31 This region has a high intrinsic beta sheet secondary structure, which presumably participates in amyloid fibril formation. The pri-mary amino acid sequence in this region is highly vanable among species.24 For example, the region spanning residues 20-29 of mousehat IAPP, which does not form amyloid fibrils, contains three proline residues. Proline residues disrupt the beta sheet secondary structure and, therefore, prevent amyloidogenesis. Such variations in IAPP structure probably explain the variable propensity among species to develop islet amyloidosis.
The present retrospective study was undertaken to characterize the prevalence, extent, and derivation of the islet amyloid in diabetic cynomolgus macaques and to identify concurrent changes in beta cell mass and islet morphology. These features were assessed in comparison with the morphologic characteristics of islets in age-matched nondiabetic macaques and human patients with NIDDM. As a part of the characterization of the amyloid, we also established the cDNA-predicted amino acid sequence of cynomolgus IAPP for comparisons with human IAPP and IAPPs of other species that develop age-associated forms of diabetes mellitus.
Materials and Methods

Animals
All macaques in the present study were members of a breeding colony of approximately 500-600 animals maintained at the Bowman Gray School of Medicine, Wake Forest University. All were part of ongoing studies concerning dietinduced atherosclerosis and were fed either standard monkey chow (High Protein Monkey Chow 5045, Purina Mills, St. Louis, MO) or an atherogenic diet containing 0.4 mg cho-le~terol/kcal.*~ Clinical procedures involving animals were conducted in compliance with state and federal laws, standards of the US Department of Health and Human Services, and guidelines established by the Institutional Animal Care and Use Committee of Wake Forest University.
The present retrospective study included four cynomolgus macaques classified as having diabetes mellitus (fasting blood glucose > 140 mg/dl) and 12 nondiabetic, age-matched controls. The diabetic group was comprised of one male and three female macaques. The mean (range) age at death for this group was 16 (1 1-22) years. The nondiabetic group was comprised of four males and eight females. The mean (range) age at death for this group was 17 (1 2-2 1) years. There was no significant difference in mean age between groups (P = 0.8). Sex, age, and recent blood glucose data for each animal are given in Table 1 . Fasting blood samples for glucose measurements were obtained during the course of the atherosclerosis studies as a part of established protocols. Blood glucose concentrations were measured by the glucose oxidase technique on a Beckman Analyzer 2.
Morphology and morphometry
Following natural death or euthanasia, all animals were subject to a complete necropsy examination. At necropsy, samples from the body or tail of the pancreas were collected from each animal and fixed in 10% neutral buffered formalin. Tissues were routinely processed for light microscopy, paraffin embedded, sectioned 5 pm thick, and placed on glass slides or on poly-L-lysine-coated slides for immunohistochemical evaluation. Pancreatic sections were routinely stained with hematoxylin and eosin and Congo red. Congo red-stained sections of pancreas were evaluated by bright field microscopy and with cross-polarized light to detect the presence of islet amyloid. Serial sections were also immunohistochemically stained for insulin and IAPP, as previously described. 22 Morphometric analyses ofpancreatic islets were performed using a Nikon microscope fitted with a Sony color television camera interfaced with an Image 1 image analysis system. For determination of pancreatic islet area fractions (i.e., proportion of islet area to total pancreatic area [endocrine plus exocrine area]), five grid fields were counted on hematoxylin and eosin stained sections from each case using the 4 x objective lens. Grid fields were comprised of 352 points (22 x 16) spaced 200 pm apart, for a total area of coverage five fields) of 70.4 mm2. This grid size and sample area of pancreas were sufficient to obtain a coefficient of variation that was < 10% for repeated measurements of islet area fraction for each animal. In animals from which there was more than one section of pancreas, the sections were numbered and one was chosen randomly for evaluation. A point of origin was chosen for each sample such that it was possible to collect five noncontiguous successive fields across the sample section. When the initial section was not large enough to allow counting of five fields, another section was randomly chosen and sufficient fields counted to total five. For each grid field (352 points), points were separated into those falling on islets and those not on pancreas (points off the section, artifactual spaces, fibrous connective tissue). Islet area fraction was expressed as points on islets/(total grid points minus points not on pancreas).
Measurements of islet area and insulin-staining area of each islet were done on the insulin-immunostained sections using the planimetry and color analysis features, respectively, of the Image 1 system ( l o x objective lens). A section of pancreas from each animal was randomly identified, and a point falling within the identified section was randomly chosen as a starting place for evaluation. Evaluation of 15 successive islets was sufficient to provide a coefficient of variation of <lo%. Islet area was determined by tracing the perimeter of each islet (with calibration set for the magnification using the 10 x objective). Insulin-staining area was then determined on the same islet by color analysis using the color contrast between the red-brown-stained regions representing insulin versus surrounding nonstained or blue (he-matoxy1in)-counterstained regions.
To assess the percentage of islets having islet amyloid deposits, one Congo red-stained section (if more than one was available) was randomly chosen, and a random point falling within this section was used as a starting point for evaluation. Islets within successive, nonoverlapping fields were then assessed for the presence of amyloid until 50 islets were evaluated.
Measurement of the amyloid area fraction of islets was done on the Congo red-stained sections using the planimetry feature of the Image 1 system to measure islet area; point counting was used to measure the amyloid area. A section from each case was randomly identified, and a point falling within the identified section was randomly chosen as a starting point for evaluation. Islet area was determined by tracing the perimeter of 10 successive islets (with calibration set for the magnification using the 10 x objective). A grid with line spacing of 80 pm was then overlaid on the image, and points covering amyloid were counted. Amyloid area fraction was then computed as (total points counted on amyloid x 1,600 pm*)/total area of islets evaluated.
Statistical analysis
Comparisons of variables between diabetic and nondiabetic macaques were done using the Mann-Whitney rank sum test.
Determination of IAPP cDNA sequence
Genomic DNA from three normal and three diabetic adult cynomolgus macaques was isolated from whole blood, which was collected in ethylenediaminetetraacetic acid and held at 4 C until used. DNA was isolated by combining 400 11. 1 of whole blood with 50 pl proteinase K (1 mglml), 33 pl of 3 M sodium acetate (pH 5.2), and 25 p1 20% sodium dodecyl sulfate, followed by incubation at 65 C for 1 hour. The mixture was then heated to 95 C to inactivate proteinase K. DNA was purified using Microcon 30 microconcentrators (Amicon, Beverly, MA).
Macaque IAPP DNA was amplified using the polymerase chain reaction (PCR) technique essentially as previously re-PCR amplifications were performed on 3.0 pl of the genomic DNA using the following two oligonucleotide primers: 5' AAATGCAACACTGCCACATG 3' (corresponding to codons 1-7 of human IAPP) and 5' TCCT-CTT(GT)CCATATGTATTG 3' (corresponding to the last 10 nucleotides of the carboxy terminus of human IAPP and 10 nucleotides of the carboxy terminal propeptide). Amplification was carried out for 30 cycles of 95 C for 1 minute, 50 C for 1 minute, and 72 C for 1 minute. To increase the specificity of the reaction, dimethyl sulfoxide was added to the reaction buffer, and the mixture was heated to 80 C before addition of the dNTPs.
Amplification products were identified on a 3% agarose gel and purified using Microcon 30 microconcentrators. Dideoxy sequencing was carried out using 3zP end-labeled PCR 
Results
Morphology and morphometric analysis of pancreatic islets
Using bright field microscopy on Congo red-stained sections, islet amyloid was identified in the islets of 12 of the 16 macaques included in this study. These amyloid deposits had typical orange-red staining with Table 3 . Consensus nucleotide sequence of PCR-a bright field microscopy and green birefringence with cross-polarized illumination (Fig. 1 ). The appearance of the amyloid deposits varied from small, isolated, punctate deposits (most often seen in cases with minimal islet amyloid) to thick seams or lakes of amyloid that replaced much of the islet and surrounded remaining islet cells. The small punctate amyloid deposits often appeared to be surrounded by the cytoplasm of an islet (beta) cell and therefore appeared to be intracellular. Immunohistochemically, all of the islet amyloid deposits showed moderate to strong immunoreactivity for IAPP and none for insulin ( Fig. 2) .
Islet amyloid deposits were present in 8 of the 12 nondiabetic macaques and in all 4 diabetic macaques ( Table 2) . Although there was no statistical difference in prevalence of islet amyloidosis between groups, there was a significant difference in extent of islet amyloidosis between groups (P < 0.001, Table 2 ). Thus, on average, the diabetic macaques had 60% and the nondiabetic animals had 6.8% of their islet areas occupied by amyloid. Group comparisons of other morphometric data revealed that the diabetic group had significantly larger mean islet area (i.e., larger islets, P = 0.01) and a larger islet area fraction (P = 0.02) than did the age-matched nondiabetic animals. Although the nondiabetic group had a greater mean percentage of insulin area in pancreatic islets than did the nondiabetics, this difference was not statistically significant (P = 0.5).
IAPP cDNA sequence
Repeated nucleotide sequence analysis of PCR amplified cDNA from normal and diabetic cynomolgus macaques provided a consensus nucleotide sequence for IAPP of this species ( Table 3 ). The sequence for all but codon 12 of IAPP,_,, was unequivocally identified. The corresponding confirmed amino acid sequence for cynomolgus monkey IAPP was identical to that of the pig-tail macaque (Macaca rzemestrina)26 and showed extensive amino acid identity with human,3 feline,2 and murine19 IAPP ( Table 4 ). In comparison with other species, the cDNA-predicted macaque IAPP amino acid sequence shows the highest degree of identity with human IAPP (92%) and less overall identity with domestic cat (86%) or mouse/rat (84%) IAPP. The sequence divergences are mostly due to differences in amino acid residues in the 20-29 region of the mole-.mplified IAPP cDNA from cynomolgus macaque.* cules. Notably, the amino terminal (1-1 9) and carboxy terminal (30-37) sequences are very highly conserved across all species ( Table 4 ).
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Discussion
The present study contributes important morphologic and biochemical data that support the concept that spontaneous diabetes mellitus in cynomolgus macaques may serve as a model of human NIDDM. Because islet amyloidosis is a typical feature of the pancreatic islets of human beings with NIDDM, it is especially important that any putative animal models of this condition have this islet 1esi0n.I~ Virtually all of the pancreatic islets of diabetic cynomolgus macaques we studied contained extensive amyloid deposits. These deposits showed the characteristic histochemical features of amyloid (i.e., congophilia and green birefringence using cross-polarized light) and exhibited immunoreactivity to antisera specific for IAPP. Islet amyloid deposits in the diabetic macaques replaced 46-74% of the total islet area. In comparison, none of the age-matched, nondiabetic macaques had more than 24% of the islet area replaced by amyloid, and four macaques had no detectable islet amyloid. Thus, just as in human beings5,21,30 and cats,35 islet amyloid deposits are significantly more extensive in individuals with diabetes mellitus than in age-matched, nondiabetic controls. Furthermore, islet amyloid deposits in cynomolgus macaques, like those of human beings and cats with NIDDM, are derived from the normal beta cell product IAPP.
The morphometric findings in the present study mirrored those described in a recent study of rhesus macaques (Macaca r n~l a t t a ) .~ In rhesus macaques, there was a progressive increase in mean islet size and islet area as a proportion of total pancreatic area (islet area fraction) as the animals progressed from the nondiabetic state, through hyperinsulinemia, and finally into overt diabetes mellitus. Concurrently, the hyperinsulinemic rhesus macaques showed an increase in beta cell area, whereas diabetic animals had reduced beta cell area and extensive IAPP-derived islet amyloid deposits. A similar progression appeared to occur in these cynomolgus macaques, as indicated by islet hyperplasia in some nondiabetics and the occurrence of rela-tively large islets in three of the four diabetic animals. The average size of pancreatic islets in the diabetic cynomolgus macaques was significantly greater (P = 0.04) than that in the nondiabetic group. The beta cell area (as estimated by mean insulin-staining area) in the cynomolgus macaques was highly variable. This variability appeared to be, at least in part, due to the animals being at different stages of disease, similar to what was noted in the study of rhesus macaques.' Thus, the pathogenesis of the diabetic state in both of these macaque species involves a similar sequence of events within the pancreatic islets, which begins with islet hyperplasia and ultimately leads to islet amyloid deposition and marked loss of beta cells.
The role of islet amyloidosis in the pathogenesis of human NIDDM has been controversial. The apparent lack of islet amyloidosis in some patients with NIDDM2' was interpreted by some to indicate that islet amyloidosis is merely an epiphenomenon and is not involved in the causation of the disease. However, with the recent documentation and genetic characterization of NIDDM subtypes (i.e., maturity onset diabetes of the young, it has become increasingly evident that human NIDDM is a heterogenous entity with more than one pathogenic mechanism involved. Furthermore, recent s t~d i e s~,~,~~ indicate that pathologic aggregations of IAPP, either as islet amyloid or in nonfibrillar deposits, may be underestimated at the level of light microscopy. Previous studies in Celebes black macaques (M. nigra)12 and rhesus macaques7Jl have shown a consistent pattern of disease in these animal models, with both species exhibiting the uniform occurrence of islet amyloid seen in animals with diabetes mellitus. Moreover, these studies have supported the view that islet amyloid deposits develop in animals prior to the onset of overt hyperglycemia, progress to more extensive deposits in the diabetic animals, and are associated with concurrent loss of beta ~e l l s .~J~ Our previous29 and present studies in cynomolgus macaques also support this pattern of involvement of islet amyloid in the pathogenesis of diabetes mellitus. Further support for a role of islet amyloid in the pathogenesis of NIDDM was provided in recent in vitro experiments that showed a toxic effect of IAPP-derived amyloid fibrils on beta cells in isolated islets. 20 In other studies, COS-1 cells transfected with human IAPP de-veloped intracellular IAPP-derived amyloid deposits and had a greater cell death rate than did cells transfected with nonamyloidogenic rat IAPP.23 These findings support the notion that islet amyloid contributes to the loss of beta cells in NIDDM and thereby contributes to the loss of glucose homeostasis. Further studies are needed to identify the precise course of events within the beta cell that lead to amyloidogenesis and to correlate these events with alterations in beta cell function.
Another important aspect of the pathogenesis of islet amyloidosis is the fact that this condition develops only in certain mammalian species.Is IAPPs of only certain species aggregate into amyloid fibril^.^' Therefore, the sequence of cynomolgus IAPP was of interest to help confirm or refute this hypothesis. Analysis of the cDNA-predicted amino acid sequence of cynomolgus macaque IAPP showed that it is identical to that of the pig-tail macaque,26 another species known to develop islet amyloid in association with diabetes mellitus. In the region spanning the critical amyloidogenic residues (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) , the IAPP sequence of both of these macaque species differs from human IAPP only at residue 25.34 Both cynomolgus and pig-tail macaques have threonine at this position rather than alanine, as do several other species with amyloidogenic IAPP. [16] [17] [18] 33, 34 This observation is consistent with a previous in vitro study in which substitution of proline for seine at residue 25 of human IAPP only slightly inhibited in vitro amyloid fibril f~r m a t i o n .~~ Thus, the cDNA-predicted amino acid sequence of cynomolgus macaque IAPP is consistent with previous work indicating the importance of IAPP residues 20-29 in islet amyloid formation.
Animal models of NIDDM could be used to assess the efficacy of various treatment modalities on the development and progression of islet lesions and to assess the relationship between the development of islet amyloidosis and the clinical development and progression of diabetes mellitus. Because prospective interventional studies to assess the development of lesions in the pancreatic islets are not ethically possible to conduct in human beings, it is important to have an animal model as closely related as possible to human NIDDM to provide a meaningful analysis of potential treatments. Our previous showed that the clinical features of spontaneous diabetes mellitus in the cynomolgus macaque parallel those of human NIDDM, and the current study documents the prominent development of IAPP-derived islet amyloidosis in these animals, which also recapitulates the human disease. Therefore, our previous and current studies of diabetes mellitus in the cynomolgus macaque indicate that this is an excellent model of human NIDDM, both clinically and pathologically, and support its use in future studies aimed at the prevention or amelioration of NIDDM.
